State Street’s Neos Therapeutics, Inc NEOS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-24,425
| Closed | -$15K | – | 3991 |
|
|
2020
Q4 | $15K | Hold |
24,425
| – | – | ﹤0.01% | 3875 |
|
|
2020
Q3 | $13K | Hold |
24,425
| – | – | ﹤0.01% | 3813 |
|
|
2020
Q2 | $17K | Hold |
24,425
| – | – | ﹤0.01% | 3776 |
|
|
2020
Q1 | $18K | Hold |
24,425
| – | – | ﹤0.01% | 3707 |
|
|
2019
Q4 | $37K | Sell |
24,425
-14,961
| -38% | -$22.4K | ﹤0.01% | 3742 |
|
|
2019
Q3 | $58K | Sell |
39,386
-5,095
| -11% | -$8.25K | ﹤0.01% | 3710 |
|
|
2019
Q2 | $57K | Sell |
44,481
-619,655
| -93% | -$1.14M | ﹤0.01% | 3713 |
|
|
2019
Q1 | $1.73M | Buy |
664,136
+107,869
| +19% | +$253K | ﹤0.01% | 3202 |
|
|
2018
Q4 | $918K | Buy |
556,267
+97,846
| +21% | +$275K | ﹤0.01% | 3345 |
|
|
2018
Q3 | $2.23M | Buy |
458,421
+36,594
| +9% | +$208K | ﹤0.01% | 3210 |
|
|
2018
Q2 | $2.64M | Buy |
421,827
+8,612
| +2% | +$64.2K | ﹤0.01% | 3144 |
|
|
2018
Q1 | $3.43M | Buy |
413,215
+5,580
| +1% | +$53.3K | ﹤0.01% | 2955 |
|
|
2017
Q4 | $4.16M | Buy |
407,635
+52,644
| +15% | +$505K | ﹤0.01% | 2881 |
|
|
2017
Q3 | $3.25M | Buy |
354,991
+38,136
| +12% | +$290K | ﹤0.01% | 2990 |
|
|
2017
Q2 | $2.31M | Buy |
316,855
+72,395
| +30% | +$547K | ﹤0.01% | 3074 |
|
|
2017
Q1 | $1.76M | Buy |
244,460
+90,099
| +58% | +$559K | ﹤0.01% | 3126 |
|
|
2016
Q4 | $903K | Buy |
154,361
+36,058
| +30% | +$244K | ﹤0.01% | 3302 |
|
|
2016
Q3 | $779K | Buy |
118,303
+13,773
| +13% | +$109K | ﹤0.01% | 3236 |
|
|
2016
Q2 | $972K | Buy |
104,530
+39,705
| +61% | +$379K | ﹤0.01% | 3280 |
|
|
2016
Q1 | $698K | Buy |
64,825
+10,786
| +20% | +$114K | ﹤0.01% | 3292 |
|
|
2015
Q4 | $774K | Buy |
54,039
+17,435
| +48% | +$263K | ﹤0.01% | 3266 |
|
|
2015
Q3 | $770K | Buy |
+36,604
| New | +$807K | ﹤0.01% | 3257 |
|
State Street's NEOS Position: Q1 2021 in Review
State Street sold out of Neos Therapeutics, Inc (NEOS) in Q1 2021, closing a stake of 24,425 shares — an estimated $15K sold.
State Street first reported a position in NEOS in Q3 2015 and held it in 22 quarters. The position peaked at $4.16M in Q4 2017. 0 funds tracked by Wall St. Rank hold NEOS as of Q1 2021.
- State Street reported no remaining Neos Therapeutics, Inc position as of Q1 2021 after selling out during the quarter.
- State Street sold 24,425 Neos Therapeutics, Inc shares in Q1 2021, an estimated $15K.
- State Street first reported a position in Neos Therapeutics, Inc in Q3 2015 and held it in 22 quarters.
- State Street's Neos Therapeutics, Inc position peaked at $4.16M in Q4 2017.
- 0 funds tracked by Wall St. Rank held Neos Therapeutics, Inc as of Q1 2021.
Based on State Street's 13F filing for Q1 2021, filed 17 May 2021.